Genetic depletion of either CD24 or Siglec-10 or blockade of the CD24–Siglec-10 interaction by monoclonal antibodies can markedly augment the phagocytosis of human breast and ovarian cancer cells [131]. Here, CD24 is linked to ovarian carcinoma.